How many institutions own BBLG stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BBLG shares is 8, representing 0.74% of the company's common stock.

Who are the major shareholders selling Bone Biologics Corporation stock?

UBS GROUP AG, in the last quarter, reduced its stake in BBLG by -100% restricting it's holding to 0 shares of worth nearly -. TOWER RESEARCH CAPITAL LLC (TRC) also lessened -46.15% of the BBLG shares from its portfolio, reducing its holding to 1.82 thousand shares of worth $1.46K. CITIGROUP INC also shunned BBLG shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying BBLG stock?

As per its latest 13F filing, GEODE CAPITAL MANAGEMENT, LLC increased its stake in BBLG by 57.63% in the last quarter. The institutional holder raised its holding to 24.2 thousand shares having worth more than $19.36K. BANK OF AMERICA CORP /DE/ also added 5% more shares of BBLG to its portfolio, raising its holding to 21 shares of worth $17.00. N/A also increased its BBLG shares holding by N/A which brought its holding to - shares worth -.

BBLG's major insiders: who are they?

The insider with the most stakes in BBLG is Hankey Don , Chairman of the Board at the company. Additionally, BBLG stock is highly held by director Hankey Bret and 10 percent owner MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. among others.

Did an insider recently sell BBLG stock?

Company executives, directors, and other insiders own 0.04% percent of Bone Biologics Corporation's stock. Within the last six months, there have been 0 transaction(s) in which BBLG insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SOO B CHIA, WU BENJAMIN, and AFH HOLDING & ADVISORY, LLC.

Which insider recently purchased BBLG stock?

There have been 0 transaction(s) during the past 6-months in which Bone Biologics Corporation insiders have bought stock, totalling 0 shares

How much of BBLG does insiders own?

Around 0 Bone Biologics Corporation shares are held by insiders, which represents about 0.04% of BBLG stock.

Who is the insider with the largest stake?

BBLG Chairman of the Board, Hankey Don holds the largest portfolio of the company's shares. BBLG shares owned by Hankey total nearly 28.56 million.

Which institution holds the most shares in BBLG?

UBS GROUP AG is the largest institutional owner in BBLG which holds 0 shares worth - or 0% of the total BBLG shares outstanding followed by with ownership of 1 shares representing 0% of the BBLG ownership. GEODE CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 24.2 thousand shares or 0.76% of the ownership worth more than $19.36K.

Is Bone Biologics Corporation stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BBLG is concerned, it is a stock which is not optionable.

Is there a short position on BBLG's shares?

Number of BBLG shares short is 26.18K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding BBLG shares are there?

As of today, 1.80M shares of BBLG are outstanding.

Is there many float in BBLG stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BBLG has 1.79M shares in float.

BBLG short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BBLG is 1.1.

Bone Biologics (BBLG) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.46

Short Percent Of Float1.46

Shares Outstanding1.80M

Shares Float1.79M

Shares Short26.18K

Short Ratio1.1

1.46%

Short % of Float

1.46%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

0.04% Percentage of Shares held by All Insiders

0.74% Percentage of Shares held by All Institutions

0.74% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 0.74% of BBLG shares are held by financial institutions. UBS GROUP AG is the top corporate investor, holding 0 shares valued at -. A 0% stake in Bone Biologics Corporation is owned by the company. owns 1 shares valued at $1.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2025	UBS GROUP AG	0%	0	-	-21.87K	-100.00%
Mar 31, 2025		0%	1	1	0	0
Mar 31, 2025	GEODE CAPITAL MANAGEMENT, LLC	0.76%	24.2K	19.36K	8.85K	+57.63%
Mar 31, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0.06%	1.82K	1.46K	-1.56K	-46.15%
Mar 31, 2025	BANK OF AMERICA CORP /DE/	0%	21	17	1	+5.00%
Mar 31, 2025	SBI SECURITIES CO., LTD.	0%	1	1	0	0
Mar 31, 2025	CITIGROUP INC	0%	0	-	-4.95K	-100.00%
Mar 31, 2025	HRT FINANCIAL LP	0%	0	-	-14.66K	-100.00%
Jun 30, 2023	WARBERG ASSET MANAGEMENT LLC	0%	0	-	-30K	-100.00%
Jun 30, 2023	UBS GROUP AG	0%	0	-	-43.65K	-100.00%
Jun 30, 2023	MFA WEALTH ADVISORS, LLC	0%	0	-	-96.77K	-100.00%
Jun 30, 2023	WALLEYE CAPITAL LLC	0%	0	-	-806.16K	-100.00%
Jun 30, 2023	SABBY MANAGEMENT, LLC	2.76%	10.82K	15.47K	-1.49M	-99.28%
Jun 30, 2023	WELLS FARGO & COMPANY/MN	0%	0	-	-52	-100.00%
Jun 30, 2023	MILLENNIUM MANAGEMENT LLC	0%	0	-	-17.82K	-100.00%
Jun 30, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-8.31K	-100.00%

Insiders

Among the BBLG insiders holding of 0.04% of the stake in company, HANKEY DON, Chairman of the Board, holds the largest shares of 28.56M. HANKEY BRET, director, is the second largest BBLG insider with ownership of 28.12M shares. MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC., 10 percent owner, stands third with possession of 11.64M shares of that stake.

Insiders	Designation	Shares Held
HANKEY DON	Chairman of the Board	28.56M
HANKEY BRET	director	28.12M
MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.	10 percent owner	11.64M
AFH HOLDING & ADVISORY, LLC	10 percent owner	3.39M
SOO B CHIA	director	2.98M
WU BENJAMIN	director	970.99K
FRELICK JEFF	Chief Executive Officer	17.2K
WALSH DEINA H	Chief Financial Officer	15K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Sep 13, 2023	WALSH DEINA H	PURCHASE	0.64	8K	5.12K	15K
Sep 11, 2023	FRELICK JEFF	PURCHASE	0.69	9.5K	6.53K	17.2K
Sep 06, 2023	WALSH DEINA H	PURCHASE	0.70	300	210	300
Aug 31, 2023	FRELICK JEFF	PURCHASE	0.66	7.6K	5.02K	7.7K
Jan 02, 2020	HANKEY DON	PURCHASE	1.00	195K	195K	28.56M
Jan 02, 2020	HANKEY BRET	PURCHASE	1.00	195K	195K	28.12M
Aug 06, 2019	HANKEY BRET	PURCHASE	0.00	553.19K	-	27.83M
Aug 06, 2019	HANKEY DON	PURCHASE	0.00	553.19K	-	28.47M
Jul 15, 2019	HANKEY BRET	PURCHASE	0.00	85.11K	-	0
Jul 15, 2019	HANKEY DON	PURCHASE	0.00	85.11K	-	27.91M
Jun 20, 2019	HANKEY BRET	PURCHASE	0.00	1.06M	-	27.19M
Jun 20, 2019	HANKEY DON	PURCHASE	0.00	1.06M	-	0
May 07, 2019	HANKEY BRET	PURCHASE	0.00	1.06M	-	26.13M
May 07, 2019	HANKEY DON	PURCHASE	0.00	1.06M	-	26.76M
Mar 25, 2019	HANKEY DON	PURCHASE	0.00	1.49M	-	25.7M
Mar 25, 2019	HANKEY BRET	PURCHASE	0.00	1.49M	-	25.06M
Dec 17, 2018	HANKEY DON	PURCHASE	0.00	18.01M	-	24.21M
Dec 17, 2018	HANKEY BRET	PURCHASE	0.00	18.01M	-	23.01M
Feb 29, 2016	MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.	PURCHASE	2.05	731.71K	1.5M	11.64M
Dec 22, 2015	SOO B CHIA	SALE	1.58	5.27K	8.33K	2.98M
Dec 22, 2015	WU BENJAMIN	SALE	1.58	2.64K	4.17K	970.99K
Nov 20, 2015	AFH HOLDING & ADVISORY, LLC	SALE	1.58	7.91K	12.5K	3.39M
Oct 09, 2015	MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.	SALE	1.58	26.37K	41.67K	973.63K
Oct 09, 2015	SOO B CHIA	SALE	1.58	52.74K	83.34K	978.9K
Oct 09, 2015	WU BENJAMIN	SALE	1.58	26.37K	41.67K	973.63K
Oct 09, 2015	AFH HOLDING & ADVISORY, LLC	SALE	1.58	79.11K	124.99K	2.47M
Sep 18, 2014	AFH HOLDING & ADVISORY, LLC	SALE	0.01	200K	1.8K	3.18M

BBLG Stock Ownership Breakdown

Bone Biologics

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions